Russian Pediatric OphthalmologyRussian Pediatric OphthalmologyРоссийская педиатрическая офтальмология1993-18592412-432XEco-Vector5089110.17816/rpo2020-15-4-27-36ReviewsНаучные обзорыResearch ArticleCystoid macular edema associated with retinitis pigmentosa: clinic, diagnostic, treatment approachesКистовидный макулярный отёк, ассоциированный с пигментным ретинитом: клиника, диагностика, подходы к лечениюhttps://orcid.org/0000-0003-3735-6249DenisovaEkaterina V.ДенисоваЕкатерина Валерьевна
Russian Federation

MD, PhD

кандидат медицинских наук, старший научный сотрудник отдела патологии глаз у детей

deale_2006@inbox.ruhttps://orcid.org/0000-0001-9422-4264KhrabrovaMariia A.ХраброваМария Алексеевна
Russian Federation

MD

аспирант отдела патологии глаз у детей

lovin68@yandex.ruFederal State Budgetary Institution «Helmholtz National Medical Research Center of Eye Diseases» of the Ministry of Health of the Russian FederationФГБУ «НМИЦ глазных болезней им. Гельмгольца» Минздрава России1512202015427362211202008022021Copyright ©; 2020, Eco-VectorCopyright ©; 2020, ООО "Эко-Вектор"2020Eco-VectorООО "Эко-Вектор"https://ruspoj.com/1993-1859/article/view/50891

Retinitis pigmentosa (RP) is a genetically determined degenerative retinal disease characterized by primary progressive degeneration of rod and secondary degeneration of cone photoreceptors. Despite the fact that the central retinal zone remains relatively intact for a long time, the most common complication of RP is macular edema (ME). The causes of ME in patients with RP have not been finally established, and treatment approaches are controversial. This article presents the modern data on the pathogenesis, clinical aspects, diagnostic, and treatment methods of ME associated with RP.

Пигментный ретинит (ПР) - генетически обусловленное дегенеративное заболевание сетчатки характеризующееся первичной прогрессирующей дегенерацией палочковых и вторичной дегенерацией колбочковых фоторецепторов. Несмотря на то, что центральная зона сетчатки длительно остаётся относительно интактной, наиболее частым осложнением ПР является макулярный отёк (МО). Причины возникновения МО у пациентов с ПР окончательно не установлены¸ а подходы к лечению неоднозначны. В обзоре рассмотрены современные данные о патогенезе, клинических проявлениях, диагностике и методах лечения МО, ассоциированного с ПР.

macular edemaretinitis pigmentosaoptical coherence tomographyfluorescence angiographycarbonic anhydrase inhibitorscorticosteroidsanti-vascular endothelial growth factor inhibitorsvitrectomyмакулярный отёкпигментный ретинитоптическая когерентная томографияфлюоресцентная ангиографияингибиторы карбоангидразыкортикостероидыингибиторы фактора роста эндотелия сосудоввитректомияArtunay O, Yuzbasioglu E, Rasier R, et al. Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa. J Ocul Pharmacol Ther. 2009;25(6):545-550. doi: 10.1089/jop.2009.0089Artunay O., Yuzbasioglu E., Rasier R., et al. Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa // J Ocul Pharmacol Ther. 2009. Vol. 25, N6. P. 545-550. doi: 10.1089/jop.2009.0089Barge S, Rothwell R, Sepúlveda P, Agrelos L. Intravitreal and subtenon depot triamcinolone as treatment of retinitis pigmentosa associated cystoid macular edema. Case Rep Ophthalmol Med. 2013;2013:591681. doi: 10.1155/2013/591681Barge S., Rothwell R., Sepúlveda P., et al. Intravitreal and subtenon depot triamcinolone as treatment of retinitis pigmentosa associated cystoid macular edema // Case Rep Ophthalmol Med. 2013. Vol. 2013. P. 591681. doi: 10.1155/2013/591681Adackapara CA, Sunness JS, Dibernardo CW, et al. Prevalence of cystoid macular edema and stability in oct retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial. Retina. 2008;28(1):103-110. doi: 10.1097/IAE.0b013e31809862aaAdackapara C.A., Sunness J.S., Dibernardo C.W., et al. Prevalence of cystoid macular edema and stability in oct retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial // Retina. 2008. Vol. 28, N1. P. 103-110. doi: 10.1097/IAE.0b013e31809862aaHajali M, Fishman GA. The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination. Eye (Lond). 2009;23(4):915-919. doi: 10.1038/eye.2008.110Hajali M., Fishman G.A. The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination // Eye (Lond). 2009. Vol. 23, N4. P. 915-919. doi: 10.1038/eye.2008.110Hirakawa H, Iijima H, Gohdo T, Tsukahara S. Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa. Am J Ophthalmol. 1999;128(2):185-191. doi: 10.1016/S0002-9394(99)00100-2Hirakawa H., Iijima H., Gohdo T., Tsukahara S. Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa // Am J Ophthalmol. 1999. Vol. 128, N2. P. 185-191. doi: 10.1016/S0002-9394(99)00100-2Kim YJ, Joe SG, Lee DH, et al. Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2013;54(2):1303–1309. doi: 10.1167/iovs.12-10149Kim Y.J., Joe S.G., Lee D.H., et al. Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa // Invest Ophthalmol Vis Sci. 2013. Vol. 54, N2. P. 1303-1309. doi: 10.1167/iovs.12-10149Küchle M, Nguyen NX, Martus P, et al. Aqueous flare in retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 1998;236(6):426-433. doi: 10.1007/s004170050101Küchle M., Nguyen N.X., Martus P., et al. Aqueous flare in retinitis pigmentosa // Graefes Arch Clin Exp Ophthalmol. 1998. Vol. 236, N6. P. 426-433. doi: 10.1007/s004170050101Sandberg MA, Brockhurst RJ, Gaudio AR, Berson EL. Visual acuity is related to parafoveal retinal thickness in patients with retinitis pigmentosa and macular cysts. Invest Ophthalmol Vis Sci. 2008;49(10):4568-4572. doi:10.1167/iovs.08-1992Sandberg M.A., Brockhurst R.J., Gaudio A.R., et al. Visual acuity is related to parafoveal retinal thickness in patients with retinitis pigmentosa and macular cysts // Invest Ophthalmol Vis Sci. 2008. Vol. 49, N10. P. 4568-4572. doi:10.1167/iovs.08-1992Testa F, Rossi S, Colucci R, et al. Macular abnormalities in Italian patients with retinitis pigmentosa. Br J Ophthalmol. 2014;98(7):946-950. doi: 10.1136/bjophthalmol-2013-304082Testa F., Rossi S., Colucci R., et al. Macular abnormalities in Italian patients with retinitis pigmentosa // Br J Ophthalmol. 2014. Vol. 98, N7. P. 946-950. doi: 10.1136/bjophthalmol-2013-304082Vinores SA, Kuchle M, Derevjanik NL, et al. Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization. Histol Histopathol. 1995;1(10):913-923.Vinores S.A, Kuchle M., Derevjanik N.L., et al. Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization // Histol Histopathol. 1995. Vol. 1, N10. P. 913-923.Reichenbach A, Wurm A, Pannicke T, et al. Muller cells as players in retinal degeneration and edema. Graefes Arch Clin Exp Ophthalmol. 2007;245(5):627-636. doi: 10.1007/s00417-006-0516-yReichenbach A., Wurm A., Pannicke T., et al. Muller cells as players in retinal degeneration and edema // Graefes Arch Clin Exp Ophthalmol. 2007. Vol. 245, N5. P. 627-636. doi: 10.1007/s00417-006-0516-yMakiyama Y, Oishi A, Otani A, et al. Prevalence and spatial distribution of cystoid spaces in retinitis pigmentosa: investigation with spectral domain optical coherence tomography. Retina. 2014;34(5):981-988. doi: 10.1097/IAE.0000000000000010Makiyama Y., Oishi A., Otani A., et al. Prevalence and spatial distribution of cystoid spaces in retinitis pigmentosa: investigation with spectral domain optical coherence tomography // Retina. 2014. Vol. 34, N5. P. 981-988. doi: 10.1097/IAE.0000000000000010Yeo JH, Kim YJ, Yoon YH. Optical coherence tomography angiography in patients with retinitis pigmentosa–associated cystoid macular edema. Retina. 2020;40(12):2385–2395. doi: 10.1097/IAE.0000000000002756Yeo J.H., Kim Y.J., Yoon Y.H. Optical coherence tomography angiography in patients with retinitis pigmentosa-associated cystoid macular edema // Retina. 2020. Vol. 40, N12. P. 2385-2395. doi: 10.1097/IAE.0000000000002756Chung H, Hwang J, Kim J. Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis. Retina. 2006;26(8):922-927. doi: 10.1097/01.iae.0000250008.83779.23Chung H., Hwang J., Kim J. Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis // Retina. 2006. Vol. 26, N8. P. 922-927. doi: 10.1097/01.iae.0000250008.83779.23Newsome DA. Retinal fluorescein leakage in retinitis pigmentosa. Am J Ophthalmol. 1986;101(3):354-360. doi: 10.1016/0002-9394(86)90831-7Newsome D.A. Retinal fluorescein leakage in retinitis pigmentosa // Am J Ophthalmol. 1986. Vol. 101, N3. P. 354-360. doi: 10.1016/0002-9394(86)90831-7Heckenlively JR, Jordan BL, Aptsiauri N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol. 1999;127(5):565-573. doi: 10.1016/s0002-9394(98)00446-2Heckenlively J.R., Jordan B.L., Aptsiauri N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa // Am J Ophthalmol. 1999. Vol. 127, N5. P. 565-573. doi: 10.1016/s0002-9394(98)00446-2Takezawa M, Tetsuka S, Kakehashi A. Tangential vitreous traction: a possible mechanism of development of cystoid macular edema in retinitis pigmentosa. Clin Ophthalmol. 2011;5(1):245-248. doi: 10.2147/OPTH.S16891Takezawa M., Tetsuka S., Kakehashi A. Tangential vitreous traction: a possible mechanism of development of cystoid macular edema in retinitis pigmentosa // Clin Ophthalmol. 2011. Vol. 5, N1. P. 245-248. doi: 10.2147/OPTH.S16891Kim C, Chung H, Gon YuH. Association of p.P347L in the rhodopsin gene with early-onset cystoid macular edema in patients with retinitis pigmentosa. Ophthalmic Genet. 2012;33(2):96-99. doi: 10.3109/13816810.2011.642453Kim C., Chung H., Gon Yu.H. Association of p.P347L in the rhodopsin gene with early-onset cystoid macular edema in patients with retinitis pigmentosa // Ophthalmic Genet. 2012. Vol. 33, N2. P. 96-99. doi: 10.3109/13816810.2011.642453Oishi A, Otani A, Sasahara M, et al. Photoreceptor integrity and visual acuity in cystoid macular oedema associated with retinitis pigmentosa. Eye (Lond). 2009;23(6):1411-1146. doi: 10.1038/eye.2008.266Oishi A., Otani A., Sasahara M., et al. Photoreceptor integrity and visual acuity in cystoid macular oedema associated with retinitis pigmentosa // Eye (Lond). 2009. Vol. 23, N6. P. 1411-1146. doi: 10.1038/eye.2008.266Sandberg MA, Brockhurst RJ, Gaudio AR, Berson EL. The association between visual acuity and central retinal thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2005;46(9):3349-3354. doi: 10.1167/iovs.04-1383Sandberg M.A., Brockhurst R.J., Gaudio A.R., et al. The association between visual acuity and central retinal thickness in retinitis pigmentosa // Invest Ophthalmol Vis Sci. 2005. Vol. 46, N9. P. 3349-3354. doi: 10.1167/iovs.04-1383Apushkin MA, Fishman GA, Janowicz MJ. Monitoring cystoid macular edema by optical coherence tomography in patients with retinitis pigmentosa. Ophthalmology. 2004;111(10):1899-1904. doi: 10.1016/j.ophtha.2004.04.019Apushkin M.A., Fishman G.A, Janowicz M.J. Monitoring cystoid macular edema by optical coherence tomography in patients with retinitis pigmentosa // Ophthalmology. 2004. Vol. 111, N10. P. 1899-1904. doi: 10.1016/j.ophtha.2004.04.019Apushkin MA, Fishman GA, Grover S, Janowicz MJ. Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa. Retina. 2007;27(8):1112-1118. doi: 10.1097/IAE.0b013e31805f6b79Apushkin M.A., Fishman G.A., Grover S., et al. Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa // Retina. 2007. Vol. 27, N8. P. 1112-1118. doi: 10.1097/IAE.0b013e31805f6b79Stanga PE, Downes SM, Ahuja RM, et al. Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies: preliminary results. Int Ophthalmol. 2001;23(4-6):321-325. doi: 10.1023/a:1014438213665Stanga P.E., Downes S.M., Ahuja R.M., et al. Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies: preliminary results // Int Ophthalmol. 2001. Vol. 23, N4-6. P. 321-325. doi: 10.1023/a:1014438213665Mosin IM, Slavinskaya NV, Korkh NL, Neudakhina EA. Kistoznyi makulyarnyi otek pri pigmentnom retinite (monitoring estestvennogo techeniya u detei s ispol’zovaniem opticheskoi kogerentnoi tomografii, elektrofiziologicheskikhi psikhofizicheskikh issledovanii). Oftal’mokhirurgiya. 2007;(2):57-62. (In Russ).Мосин И.М., Славинская Н.В., Корх Н.Л., и др. Кистозный макулярный отек при пигментном ретините (мониторинг естественного течения у детей с использованием оптической когерентной томографии, электрофизиологических и психофизических исследований) // Офтальмохирургия. 2007. №2. С. 57-62.Zolnikova V, Levina DV, Okhotsimskaya TD, et al. Electroretinography and OCT angiography of the retina and optic nerve in retinitis pigmentosa. Russian Ophthalmological Journal. 2017;10(3):22-28. (In Russ). doi: 10.21516/2072-0076-2017-10-3-22-28Зольникова И.В., Левина Д.В., Охоцимская Т.Д., и др. Электроретинография и ОКТ-ангиография сетчатки и зрительного нерва при пигментном ретините // Российский офтальмологический журнал. 2017. T. 10, №3. C. 22-28. doi: 10.21516/2072-0076-2017-10-3-22-28Minnella AM, Falsini B, Bamonte G, et al. Optical coherence tomography and focal electroretinogram evaluation of cystoid macular edema secondary to retinitis pigmentosa treated with intravitreal triamcinolone: case report. Eur J Ophthalmol. 2006;16(6):883-886. doi: 10.1177/112067210601600620Minnella A.M., Falsini B., Bamonte G., et al. Optical coherence tomography and focal electroretinogram evaluation of cystoid macular edema secondary to retinitis pigmentosa treated with intravitreal triamcinolone: case report // Eur J Ophthalmol. 2006. Vol. 16, N6. P. 883-886. doi: 10.1177/112067210601600620Karasu B. Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors. Int Ophthalmol. 2020;40(3):677-687. doi: 10.1007/s10792-019-01228-zKarasu B. Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors // Int Ophthalmol. 2020. Vol. 40, N3. P. 677-687. doi: 10.1007/s10792-019-01228-zStrong S, Liew G, Michaelides M. Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention. Br J Ophthalmol. 2017;101(1):31-37. doi: 10.1136/bjophthalmol-2016-309376Strong S., Liew G., Michaelides M. Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention // Br J Ophthalmol. 2017. Vol. 101, N1. P. 31-37. doi: 10.1136/bjophthalmol-2016-309376Fishman GA, Apushkin MA. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa. Br J Ophthalmol. 2007;91(6):743–745. doi: 10.1136/bjo.2006.107466Fishman G.A., Apushkin M.A. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa // Br J Ophthalmol. 2007. Vol. 91, N6. P. 743-745. doi: 10.1136/bjo.2006.107466Genead MA, Fishman GA. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. Arch Ophthalmol. 2010;128(9):1146-1150. doi: 10.1001/archophthalmol.2010.172Genead M.A., Fishman G.A. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome // Arch Ophthalmol. 2010. Vol. 128, N9. P. 1146-1150. doi: 10.1001/archophthalmol.2010.172Grover S, Apushkin MA, Fishman GA. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol. 2006;141(5):850-858. doi: 10.1016/j.ajo.2005.12.030Grover S., Apushkin M.A., Fishman G.A. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa // Am J Ophthalmol. 2006. Vol. 141, N5. P. 850-858. doi: 10.1016/j.ajo.2005.12.030Ikeda Y, Hisatomi T, Yoshida N, et al. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2012;250(6):809-814. doi: 10.1007/s00417-011-1904-5Ikeda Y., Hisatomi T., Yoshida N., et al. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa // Graefes Arch Clin Exp Ophthalmol. 2012. Vol. 250, N6. P. 809-814. doi: 10.1007/s00417-011-1904-5Liew G, Moore AT, Webster AR, et al. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2015;56(3):1531-156. doi: 10.1167/iovs.14-15995Liew G., Moore A.T., Webster A.R., et al. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa // Invest Ophthalmol Vis Sci. 2015. Vol. 56, N3. P. 1531-156. doi: 10.1167/iovs.14-15995Fishman GA, Gilbert LD, Anderson RJ, et al. Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. Ophthalmology. 1994;101(4):687-693. doi: 10.1016/s0161-6420(94)31277-2Fishman G.A., Gilbert L.D., Anderson R.J., et al. Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa // Ophthalmology. 1994. Vol. 101, N4. P. 687-693. doi: 10.1016/s0161-6420(94)31277-2Fishman GA, Gilbert LD, Fiscella RG, et al. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol. 1989;107(10):1445-1452. doi: 10.1001/archopht.1989.01070020519031Fishman G.A., Gilbert L.D., Fiscella R.G., et al. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa // Arch Ophthalmol. 1989. Vol. 107, N10. P. 1445-1452. doi: 10.1001/archopht.1989.01070020519031Thobani A, Fishman GA. The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis. Retina. 2011;31(2):312-315. doi: 10.1097/IAE.0b013e3181e587f9Thobani A., Fishman G.A. The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis // Retina. 2011. Vol. 31, N2. P. 312-315. doi: 10.1097/IAE.0b013e3181e587f9Scruggs BA, Chen CV, Pfeifer W, et al. Efficacy of topical brinzolamide in children with retinal dystrophies. Ophthalmic Genet. 2019;40(4):350–358. doi: 10.1080/13816810.2019.1660381Scruggs B.A., Chen C.V., Pfeifer W., et al. Efficacy of topical brinzolamide in children with retinal dystrophies // Ophthalmic Genet. 2019. Vol. 40, N4. P. 350-358. doi: 10.1080/13816810.2019.1660381Kitahata S, Hirami Y, Takagi S, et al. Efficacy of additional topical betamethasone in persistent cystoid macular oedema after carbonic anhydrase inhibitor treatments in retinitis pigmentosa. BMJ Open Ophthalmol. 2018;3(1):e000107. doi: 10.1136/bmjophth-2017-000107Kitahata S., Hirami Y., Takagi S., et al. Efficacy of additional topical betamethasone in persistent cystoid macular oedema after carbonic anhydrase inhibitor treatments in retinitis pigmentosa // BMJ Open Ophthalmol. 2018. Vol. 3, N1. P. e000107. doi: 10.1136/bmjophth-2017-000107Schaal Y, Hondur AM, Tezel TH. Subtenon triamcinolone for cystoid macular edema due to retinitis pigmentosa unresponsive to oral acetazolamide. Can J Ophthalmol. 2016;51(4):e113-115. doi: 10.1016/j.jcjo.2015.12.021Schaal Y., Hondur A.M., Tezel T.H. Subtenon triamcinolone for cystoid macular edema due to retinitis pigmentosa unresponsive to oral acetazolamide // Can J Ophthalmol. 2016. Vol. 51, N4. P. e113–e115. doi: 10.1016/j.jcjo.2015.12.021Ozdemir H, Karacorlu M, Karacorlu S. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa. Acta Ophthalmol Scand. 2005;83(2):248-251. doi: 10.1111/j.1600-0420.2005.00395.xOzdemir H., Karacorlu M., Karacorlu S. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa // Acta Ophthalmol Scand. 2005. Vol. 83, N2. P. 248-251. doi: 10.1111/j.1600-0420.2005.00395.xSaraiva VS, Sallum JM, Farah ME. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging. 2003;34(5):398–400. doi: 10.3928/1542-8877-20030901-11Saraiva V.S., Sallum J.M., Farah M.E. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide // Ophthalmic Surg Lasers Imaging. 2003. Vol. 34, N5. P. 398-400. doi: 10.3928/1542-8877-20030901-11Scorolli L, Morara M, Meduri A, et al. Treatment of cystoid macular edema in retinitis pigmentosa with intravitreal triamcinolone. Arch Ophthalmol. 2007;125(6):759-764. doi: 10.1001/archopht.125.6.759Scorolli L., Morara M., Meduri A., et al. Treatment of cystoid macular edema in retinitis pigmentosa with intravitreal triamcinolone // Arch Ophthalmol. 2007. Vol. 125, N6. P. 759-764. doi: 10.1001/archopht.125.6.759Mansour AM, Sheheitli H, Kucukerdonmez C, et al. Intravitreal dexamethasone implant in retinitis pigmentosa–related cystoid macular edema. Retina. 2018;38(2):413-423. doi: 10.1097/IAE.0000000000001542Mansour A.M., Sheheitli H., Kucukerdonmez C., et al. Intravitreal dexamethasone implant in retinitis pigmentosa–related cystoid macular edema // Retina. 2018. Vol. 38, N2. P. 413-423. doi: 10.1097/IAE.0000000000001542Donmez O, Saatci AO. Intravitreal pharmacotherapy in the treatment of retinitis pigmentosa-related cystoid macular oedema. European ophthalmic review. 2017;11(1):55-80. doi: 10.17925/EOR.2017.11.01.55Donmez O., Saatci A.O. Intravitreal pharmacotherapy in the treatment of retinitis pigmentosa-related cystoid macular oedema // European ophthalmic review. 2017. Vol. 11, N1. P. 55-80. doi: 10.17925/EOR.2017.11.01.55Srour M, Querques G, Leveziel N, et al. Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2012;251(6):1501-1506. doi: 10.1007/s00417-012-2249-4Srour M., Querques G., Leveziel N., et al. Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa // Graefes Arch Clin Exp Ophthalmol. 2012. Vol. 251, N6. P. 1501-1506. doi: 10.1007/s00417-012-2249-4Sudhalkar A, Kodjikian L, Borse N. Intravitreal dexamethasone implant for recalcitrant cystoid macular edema secondary to retinitis pigmentosa: a pilot study. Graefes Arch Clin Exp Ophthalmol. 2017;255(7):1369-1374. doi: 10.1007/s00417-017-3660-7Sudhalkar A., Kodjikian L., Borse N. Intravitreal dexamethasone implant for recalcitrant cystoid macular edema secondary to retinitis pigmentosa: a pilot study // Graefes Arch Clin Exp Ophthalmol. 2017. Vol. 255, N7. P. 1369-1374. doi: 10.1007/s00417-017-3660-7Park UC, Park JH, Ma DJ, et al. A randomized paired-eye trial of intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa. Retina. 2019;40(7):1359-1366. doi: 10.1097/IAE.0000000000002589Park U.C., Park J.H., Ma D.J., et al. A randomized paired-eye trial of intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa // Retina. 2019. Vol. 40, N7. P. 1359-1366. doi: 10.1097/IAE.0000000000002589Chang YS, Wu CL, Tseng SH, et al. Cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: comparison with dexamethasone and hydrocortisone. Jpn J Ophthalmol. 2004;48(3):236-242. doi: 10.1007/s10384-003-0053-8Chang Y.S., Wu C.L., Tseng S.H., et al. Cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: comparison with dexamethasone and hydrocortisone // Jpn J Ophthalmol. 2004. Vol. 48, N3. P. 236-242. doi: 10.1007/s10384-003-0053-8Giusti C, Forte R, Vingolo EM. Deflazacort treatment of cystoid macular edema in patients affected by Retinitis Pigmentosa: a pilot study. Eur Rev Med Pharmacol Sci. 2002;6(1):1-8.Giusti C., Forte R., Vingolo E.M. Deflazacort treatment of cystoid macular edema in patients affected by Retinitis Pigmentosa: a pilot study // Eur Rev Med Pharmacol Sci. 2002. Vol. 6, N1. P. 1-8.Querques G, Prascina F, Iaculli C, Noci ND. Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa. Int Ophthalmol. 2007;29(2):103-107. doi: 10.1007/s10792-007-9175-1Querques G., Prascina F., Iaculli C., Noci N.D. Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa // Int Ophthalmol. 2007. Vol. 29, N2. P. 103-107. doi: 10.1007/s10792-007-9175-1Yuzbasioglu E, Artunay O, Rasier R, et al. Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa. Curr Eye Res. 2009;34(3):231-237. doi: 10.1080/02713680802710692Yuzbasioglu E., Artunay O., Rasier R., et al. Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa // Curr Eye Res. 2009. Vol. 34, N3. P. 231-237. doi: 10.1080/02713680802710692Melo GB, Farah ME, Aggio FB. Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa. Acta Ophthalmol Scand. 2007;85(4):461-443. doi: 10.1111/j.1600-0420.2006.00872.xMelo G.B., Farah M.E., Aggio F.B. Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa // Acta Ophthalmol Scand. 2007. Vol. 85, N4. P. 461-443. doi: 10.1111/j.1600-0420.2006.00872.xMoustafa GA, Moschos MM. Intravitreal aflibercept (Eylea) injection for cystoid macular edema secondary to retinitis pigmentosa – a first case report and short review of the literature. BMC Ophthalmol. 2015;15(44):1-6. doi: 10.1186/s12886-015-0033-zMoustafa G.A., Moschos M.M. Intravitreal aflibercept (Eylea) injection for cystoid macular edema secondary to retinitis pigmentosa – a first case report and short review of the literature // BMC Ophthalmol. 2015. Vol. 15, N44. P. 1-6. doi: 10.1186/s12886-015-0033-zStrong S, Peto T, Bunce C, et al. Prospective exploratory study to assess the safety and efficacy of aflibercept in cystoid macular oedema associated with retinitis pigmentosa. Br J Ophthalmol. 2020;104(1):1203-1208. doi: 10.1136/bjophthalmol-2019-315152Strong S., Peto T., Bunce C., et al. Prospective exploratory study to assess the safety and efficacy of aflibercept in cystoid macular oedema associated with retinitis pigmentosa // Br J Ophthalmol. 2020. Vol. 104, N1. P. 1203-1208. doi: 10.1136/bjophthalmol-2019-315152Garcia-Arumi J, Martinez V, Sararols L, Corcostegui B. Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa. Ophthalmology. 2003;110(6):1164-1169. doi: 10.1016/S0161-6420(03)00259-8Garcia-Arumi J., Martinez V., Sararols L., et al. Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa // Ophthalmology. 2003. Vol. 110, N6. P. 1164-1169. doi: 10.1016/S0161-6420(03)00259-8Hagiwara A, Yamamoto S, Ogata K, et al. Macular abnormalities in patients with retinitis pigmentosa: prevalence on OCT examination and outcomes of vitreoretinal surgery. Acta Ophthalmol. 2011;89(2):122-125. doi: 10.1111/j.1755-3768.2010.01866.xHagiwara A., Yamamoto S., Ogata K., et al. Macular abnormalities in patients with retinitis pigmentosa: prevalence on OCT examination and outcomes of vitreoretinal surgery // Acta Ophthalmol. 2011. Vol. 89, N2. P. 122-125. doi: 10.1111/j.1755-3768.2010.01866.x